HYDROMORPHONE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of HYDROMORPHONE HYDROCHLORIDE INJECTION (NSN 6505016855760) at a total price of $8.04, with delivery required by July 20, 2026. The item is to be delivered FOB destination to the U.S. Navy shipboard location at N23410, PCU JOHN F KENNEDY CVN-79 in Suffolk, Virginia, with the contractor bearing all freight costs and risk of loss until receipt. The contract references DD Form 1155 for shipping documentation and mandates invoice submission per DFARS 252.232-7003, with payments processed through the Defense Finance and Accounting Service in Columbus, Ohio. Inspection and acceptance occur at the destination by an authorized government representative, though no specific quality or technical standards beyond conformity to contract specifications are detailed. The awardee self-certifies as a Small Business, Small Disadvantaged Business, and Women-Owned Small Business, triggering associated reporting obligations under FAR provisions. Packaging, labeling, and barcoding requirements are minimal, listing only the NSN, CAGE codes (1UNB0, 32655, 57KZ6), and NDC number (00641-6151-25) without adherence to MIL-STD-129 or other military packaging standards. The procurement is administered by Lisa Quinn as Contracting Officer and Shairy M. Cartagena as the administrative point of contact, with no special clauses, security requirements, or options identified. The order reflects a low-value, straightforward acquisition under an existing IDIQ vehicle, likely processed under a Lowest Price Technically Acceptable approach, with no evidence of competitive evaluation criteria or alternative pricing considerations.